Cargando…

Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period

Early poliovirus vaccines, both inactivated and live attenuated, were inadvertently contaminated with simian virus 40 (SV40), a monkey virus known to be oncogenic for newborn hamsters. Although large epidemiologic studies have not identified an elevated cancer risk in persons who received SV40-conta...

Descripción completa

Detalles Bibliográficos
Autores principales: Carroll-Pankhurst, C, Engels, E A, Strickler, H D, Goedert, J J, Wagner, J, Jr, E A Mortimer
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375249/
https://www.ncbi.nlm.nih.gov/pubmed/11720463
http://dx.doi.org/10.1054/bjoc.2001.2065
_version_ 1782154612405436416
author Carroll-Pankhurst, C
Engels, E A
Strickler, H D
Goedert, J J
Wagner, J
Jr, E A Mortimer
author_facet Carroll-Pankhurst, C
Engels, E A
Strickler, H D
Goedert, J J
Wagner, J
Jr, E A Mortimer
author_sort Carroll-Pankhurst, C
collection PubMed
description Early poliovirus vaccines, both inactivated and live attenuated, were inadvertently contaminated with simian virus 40 (SV40), a monkey virus known to be oncogenic for newborn hamsters. Although large epidemiologic studies have not identified an elevated cancer risk in persons who received SV40-contaminated vaccines, fragments of SV40 DNA have recently been identified in certain human tumours. We report the follow-up of a cohort of 1073 persons, unique because they received SV40-contaminated poliovirus vaccines as newborns in 1961–63. A previous report of the status of these subjects as of 1977–79 identified 15 deaths, none due to cancer. The present study utilized the National Death Index to identify deaths in the cohort for the years 1979–96. Expected deaths were calculated from Cleveland area sex-, age-, race- and year-specific mortality rates. Increased mortality from all causes was not found. 4 deaths from cancer were found compared to 3.16 expected (P= 0.77). However, 2 deaths from testicular cancer occurred, compared to 0.05 expected (P= 0.002), which may be a chance finding due to multiple comparisons. There were 2 deaths due to leukaemia, a non-significant finding, and no deaths due to tumours of the types putatively associated with SV40. Although these results are, for the most part, consistent with other negative epidemiologic investigations of risks from SV40-contaminated vaccines, further study of testicular cancer may be warranted, and it will be important to continue monitoring this cohort which is now reaching middle-age. © 2001 Cancer Research Campaign
format Text
id pubmed-2375249
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23752492009-09-10 Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period Carroll-Pankhurst, C Engels, E A Strickler, H D Goedert, J J Wagner, J Jr, E A Mortimer Br J Cancer Regular Article Early poliovirus vaccines, both inactivated and live attenuated, were inadvertently contaminated with simian virus 40 (SV40), a monkey virus known to be oncogenic for newborn hamsters. Although large epidemiologic studies have not identified an elevated cancer risk in persons who received SV40-contaminated vaccines, fragments of SV40 DNA have recently been identified in certain human tumours. We report the follow-up of a cohort of 1073 persons, unique because they received SV40-contaminated poliovirus vaccines as newborns in 1961–63. A previous report of the status of these subjects as of 1977–79 identified 15 deaths, none due to cancer. The present study utilized the National Death Index to identify deaths in the cohort for the years 1979–96. Expected deaths were calculated from Cleveland area sex-, age-, race- and year-specific mortality rates. Increased mortality from all causes was not found. 4 deaths from cancer were found compared to 3.16 expected (P= 0.77). However, 2 deaths from testicular cancer occurred, compared to 0.05 expected (P= 0.002), which may be a chance finding due to multiple comparisons. There were 2 deaths due to leukaemia, a non-significant finding, and no deaths due to tumours of the types putatively associated with SV40. Although these results are, for the most part, consistent with other negative epidemiologic investigations of risks from SV40-contaminated vaccines, further study of testicular cancer may be warranted, and it will be important to continue monitoring this cohort which is now reaching middle-age. © 2001 Cancer Research Campaign Nature Publishing Group 2001-11 2001-09-01 /pmc/articles/PMC2375249/ /pubmed/11720463 http://dx.doi.org/10.1054/bjoc.2001.2065 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Carroll-Pankhurst, C
Engels, E A
Strickler, H D
Goedert, J J
Wagner, J
Jr, E A Mortimer
Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period
title Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period
title_full Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period
title_fullStr Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period
title_full_unstemmed Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period
title_short Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period
title_sort thirty-five year mortality following receipt of sv40- contaminated polio vaccine during the neonatal period
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375249/
https://www.ncbi.nlm.nih.gov/pubmed/11720463
http://dx.doi.org/10.1054/bjoc.2001.2065
work_keys_str_mv AT carrollpankhurstc thirtyfiveyearmortalityfollowingreceiptofsv40contaminatedpoliovaccineduringtheneonatalperiod
AT engelsea thirtyfiveyearmortalityfollowingreceiptofsv40contaminatedpoliovaccineduringtheneonatalperiod
AT stricklerhd thirtyfiveyearmortalityfollowingreceiptofsv40contaminatedpoliovaccineduringtheneonatalperiod
AT goedertjj thirtyfiveyearmortalityfollowingreceiptofsv40contaminatedpoliovaccineduringtheneonatalperiod
AT wagnerj thirtyfiveyearmortalityfollowingreceiptofsv40contaminatedpoliovaccineduringtheneonatalperiod
AT jreamortimer thirtyfiveyearmortalityfollowingreceiptofsv40contaminatedpoliovaccineduringtheneonatalperiod